There is evidence that malignant transformation is related to cell proliferation and is specifically dependent on DNA replication. Thus, the structural damage inflicted upon the genetic material by chemical carcinogens is necessary but not sufficient to initiate the process of chemical carcinogenesis. Only with the subsequent occurrence of DNA replication, those alterations not yet eliminated by error-free repair could be converted into actual transforming lesions. The probability that a cell will be transformed by a chemical carcinogen is related not only to the frequency of DNA damage (modulated by carcinogen dose and DNA repair) in specific DNA sequences (proto-oncogenes?), but also, to the molecular mechanisms of replication of structurally altered DNA. One of our main premises is that the process of neoplastic transformation is genetically determined and shares important mechanistic characteristics with the process of gene mutation. This could explain the S phase dependence of transformation and mutation observed in many systems. The higher susceptibility to malignant transformation observed when cells are treated in late GI or early S phase, as compared to other points in the cell cycle, is probably due to damage to specific cellular genes at or close to the time of their replication. Alternatively, a lower rate of repair during the S phase would also increase the probability of fixation of a genetic alteration, independently of the timing of replication of the damaged DNA sequence. In this Program Project we will pool our individual expertise to obtain solid experimental evidence to support or refute these hypotheses. We propose this Program Project Grant to bring together the goals and efforts described above for the individual grants into three major research areas: 1) phenomenological characterization of malignant transformation in three distinct model systems, i.e., C3H 10T1/2 and human fibroblasts in vitro and liver cells in vivo; 2) mechanistic studies of DNA replication and repair; 3) characterization of genetic and molecular mechanisms for transformation and mutations. In each of these areas the main emphasis will be on the cell-cycle variations of the different end-points mentioned above.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
3P01CA042765-05S1
Application #
3093988
Study Section
Special Emphasis Panel (SRC (Y1))
Project Start
1988-04-01
Project End
1994-06-30
Budget Start
1992-04-01
Budget End
1994-06-30
Support Year
5
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Deming, Paula B; Flores, Kristina G; Downes, C Stephen et al. (2002) ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase. J Biol Chem 277:36832-8
Kaufmann, William K; Campbell, Christine B; Simpson, Dennis A et al. (2002) Degradation of ATM-independent decatenation checkpoint function in human cells is secondary to inactivation of p53 and correlated with chromosomal destabilization. Cell Cycle 1:210-9
Brylawski, B P; Cohen, S M; Longmire, J L et al. (2000) Construction of a cosmid library of DNA replicated early in the S phase of normal human fibroblasts. J Cell Biochem 78:509-17
Shackelford, R E; Kaufmann, W K; Paules, R S (2000) Oxidative stress and cell cycle checkpoint function. Free Radic Biol Med 28:1387-404
Brylawski, B P; Cohen, S M; Cordeiro-Stone, M et al. (2000) On the relationship of matrix association and DNA replication. Crit Rev Eukaryot Gene Expr 10:91-9
Jiang, X R; Jimenez, G; Chang, E et al. (1999) Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 21:111-4
Kaufmann, W K (1998) Human topoisomerase II function, tyrosine phosphorylation and cell cycle checkpoints. Proc Soc Exp Biol Med 217:327-34
Cohen, S M; Cobb, E R; Cordeiro-Stone, M et al. (1998) Identification of chromosomal bands replicating early in the S phase of normal human fibroblasts. Exp Cell Res 245:321-9
Gualberto, A; Aldape, K; Kozakiewicz, K et al. (1998) An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control. Proc Natl Acad Sci U S A 95:5166-71
Kaufmann, W K; Kies, P E (1998) DNA signals for G2 checkpoint response in diploid human fibroblasts. Mutat Res 400:153-67

Showing the most recent 10 out of 48 publications